Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Value Peer-spectives
Filter by Topic
ASCO’s Value Framework
Commentary
Employers’ Perspective
Letter to our Readers
Oncologist–Patient Communication
Patient Communication
Patient Perspective
Payer’s Perspective
Practice Management
Testimonials
The Patient Perspective
Value in Oncology
Value Propositions
VBCC Perspectives
21st Century Oncology Administering First Commercial Dose of Xofigo for Advanced Prostate Cancer
Value Propositions
,
Value Peer-spectives
June 2013, Vol 4, No 5
Read Article
In Search of £1 Million to Confirm Value of First Genetically Engineered Oncolytic Virus for Neuroendocrine Cancer
Value Propositions
,
Value Peer-spectives
June 2013, Vol 4, No 5
Neuroendocrine cancer, a rare type of cancer (that became well known after Steve Jobs was diagnosed with and died from a neuroendocrine cancer of the pancreas), may have a new lease on life, if Swedish researchers of Uppsala University in Sweden find a way of obtaining £1 million (approximately $1.5 million) to support their research.
Read Article
Genetic Testing a Potential Game Changer in the Approach to Endometrial Cancer
Value Propositions
,
Value Peer-spectives
June 2013, Vol 4, No 5
Researchers have analyzed the genetic makeup of hundreds of endometrial tumors that may lead to targeted therapies for subpopulations of patients with this deadly cancer.
Read Article
Popularizing Cancer as a Topic of Public Discourse
By
Craig Deligdish, MD
From the Editor
,
Value Peer-spectives
June 2013, Vol 4, No 5
With the Third Annual Conference of the Association for Value-Based Cancer Care (AVBCC) held in May in Florida and the 2013 Annual Meeting of the American Society of Clinical Oncology concluding in June in Chicago, it is tempting to consider which of the many presentations, abstracts, and reports were most impactful or will have the greatest influence on how oncologists think about, diagnose, and treat patients with cancer.
Read Article
Health IT Facilitates Patient Engagement Across Many Settings
By
Caroline Helwick
Practice Management
,
Value Peer-spectives
May 2013, Vol 4, No 4
New Orleans, LA—“Patient engagement” is a healthcare buzz phrase, and a critical part of this concept is patient connectivity to information technology (IT). GetWellNetwork is a patient-focused IT system that aims to empower the patient to improve outcomes in a variety of disease states.
Read Article
First Recipients of Bridge Grants to Support Hematologic Research Announced
Value Propositions
,
Value Peer-spectives
May 2013, Vol 4, No 4
Read Article
Powerful Algorithms Help Decipher the Genetics of Cancer
Value Propositions
,
Value Peer-spectives
May 2013, Vol 4, No 4
Using data-sifting algorithms developed by computer scientists at Brown University, researchers are beginning to untangle the complex genetics of cancer. In a new study published in the
New England Journal of Medicine,
investigators have outlined the most complete genetic profile of acute myeloid leukemia (AML).
Read Article
New Genomic Classification of Endometrial Cancers Will Soon Guide Therapy
Value Propositions
,
Value Peer-spectives
May 2013, Vol 4, No 4
Endometrial cancer is the fourth most common malignancy among American women. The National Cancer Institute estimates that close to 50,000 women will be diagnosed with endometrial cancer in 2013; for a majority of women with aggressive, high-grade tumors, the 5-year survival rate is approximately 16%.
Read Article
First Guidelines Issued for Molecular Diagnostics Use in Patients with Lung Cancer
Value Propositions
,
Value Peer-spectives
May 2013, Vol 4, No 4
After a decade of developing molecular diagnostics for lung cancer, 3 organizations have issued the first guidelines for testing for the EGFR mutation and ALK rearrangement in patients with lung cancer, the number one cancer-related killer worldwide, providing a valuable new tool to fully utilize the benefits of targeted therapies for this patient population.
Read Article
New Approach to Treatment Resistance in Head and Neck Cancers
Value Propositions
,
Value Peer-spectives
February 2013, Vol 4, No 2
The majority of head and neck tumors are associated with a deregulation of the PI3K/AKT/mTOR pathway, which has until now been seen as the culprit in treatment resistance in these cancers.
Read Article
Page 8 of 16
3
4
5
6
7
8
9
10
11
12
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma